Global Viral Vectors and Plasmid DNA Manufacturing Sales Market Report 2023

Global Viral Vectors and Plasmid DNA Manufacturing Sales Market Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018 VS 2022 VS 2029)
1.2.2 Plasmid DNA
1.2.3 Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018 VS 2022 VS 2029)
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Perspective (2018-2029)
2.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
2.3 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Region (2018-2023)
2.4 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Region (2024-2029)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 United States Viral Vectors and Plasmid DNA Manufacturing Estimates and Projections (2018-2029)
2.5.2 Europe Viral Vectors and Plasmid DNA Manufacturing Estimates and Projections (2018-2029)
2.5.3 China Viral Vectors and Plasmid DNA Manufacturing Estimates and Projections (2018-2029)
2.5.4 Japan Viral Vectors and Plasmid DNA Manufacturing Estimates and Projections (2018-2029)
2.5.5 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Estimates and Projections (2018-2029)
2.5.6 India Viral Vectors and Plasmid DNA Manufacturing Estimates and Projections (2018-2029)
3 Global Viral Vectors and Plasmid DNA Manufacturing Competition Landscape by Players
3.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue (2018-2023)
3.1.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue (2018-2023)
3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2018-2023)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Viral Vectors and Plasmid DNA Manufacturing Revenue
3.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio
3.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2022
3.5 Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Area Served
3.6 Key Players Viral Vectors and Plasmid DNA Manufacturing Product Solution and Service
3.7 Date of Enter into Viral Vectors and Plasmid DNA Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Type
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Type (2018-2023)
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2024-2029)
5 Viral Vectors and Plasmid DNA Manufacturing Breakdown Data by Application
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Application (2018-2023)
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2024-2029)
6 United States Viral Vectors and Plasmid DNA Manufacturing Market Facts & Figures
6.1 United States Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2018-2023)
6.2 United States Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
6.2.1 United States Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023)
6.2.2 United States Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029)
6.2.3 United States Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
6.3 United States Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
6.3.1 United States Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023)
6.3.2 United States Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029)
6.3.3 United States Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
7 Europe Viral Vectors and Plasmid DNA Manufacturing Market Facts & Figures
7.1 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2018-2023)
7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
7.2.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023)
7.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029)
7.2.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
7.3.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023)
7.3.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029)
7.3.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
8 China Viral Vectors and Plasmid DNA Manufacturing Market Facts & Figures
8.1 China Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2018-2023)
8.2 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
8.2.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023)
8.2.2 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029)
8.2.3 China Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
8.3 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
8.3.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023)
8.3.2 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029)
8.3.3 China Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
9 Japan Viral Vectors and Plasmid DNA Manufacturing Market Facts & Figures
9.1 Japan Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2018-2023)
9.2 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
9.2.1 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023)
9.2.2 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029)
9.2.3 Japan Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
9.3 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
9.3.1 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023)
9.3.2 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029)
9.3.3 Japan Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
10 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Facts & Figures
10.1 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2018-2023)
10.2 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
10.2.1 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023)
10.2.2 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029)
10.2.3 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
10.3 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
10.3.1 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023)
10.3.2 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029)
10.3.3 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
11 India Viral Vectors and Plasmid DNA Manufacturing Market Facts & Figures
11.1 India Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2018-2023)
11.2 India Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
11.2.1 India Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023)
11.2.2 India Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029)
11.2.3 India Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
11.3 India Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
11.3.1 India Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023)
11.3.2 India Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029)
11.3.3 India Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
12 Key Players Profiles
12.1 BioReliance
12.1.1 BioReliance Company Details
12.1.2 BioReliance Business Overview
12.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Introduction
12.1.4 BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.1.5 BioReliance Recent Development
12.2 Cobra Biologics
12.2.1 Cobra Biologics Company Details
12.2.2 Cobra Biologics Business Overview
12.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Introduction
12.2.4 Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.2.5 Cobra Biologics Recent Development
12.3 Oxford BioMedica
12.3.1 Oxford BioMedica Company Details
12.3.2 Oxford BioMedica Business Overview
12.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Introduction
12.3.4 Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.3.5 Oxford BioMedica Recent Development
12.4 UniQure
12.4.1 UniQure Company Details
12.4.2 UniQure Business Overview
12.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Introduction
12.4.4 UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.4.5 UniQure Recent Development
12.5 FinVector
12.5.1 FinVector Company Details
12.5.2 FinVector Business Overview
12.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Introduction
12.5.4 FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.5.5 FinVector Recent Development
12.6 MolMed
12.6.1 MolMed Company Details
12.6.2 MolMed Business Overview
12.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Introduction
12.6.4 MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.6.5 MolMed Recent Development
12.7 MassBiologics
12.7.1 MassBiologics Company Details
12.7.2 MassBiologics Business Overview
12.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Introduction
12.7.4 MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.7.5 MassBiologics Recent Development
12.8 Richter-Helm
12.8.1 Richter-Helm Company Details
12.8.2 Richter-Helm Business Overview
12.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Introduction
12.8.4 Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.8.5 Richter-Helm Recent Development
12.9 FUJIFILM Diosynth Biotechnologies
12.9.1 FUJIFILM Diosynth Biotechnologies Company Details
12.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
12.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Introduction
12.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
12.10 Lonza
12.10.1 Lonza Company Details
12.10.2 Lonza Business Overview
12.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Introduction
12.10.4 Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.10.5 Lonza Recent Development
12.11 Aldevron
12.11.1 Aldevron Company Details
12.11.2 Aldevron Business Overview
12.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Introduction
12.11.4 Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.11.5 Aldevron Recent Development
12.12 Eurogentec
12.12.1 Eurogentec Company Details
12.12.2 Eurogentec Business Overview
12.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Introduction
12.12.4 Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.12.5 Eurogentec Recent Development
12.13 Cell and Gene Therapy Catapult
12.13.1 Cell and Gene Therapy Catapult Company Details
12.13.2 Cell and Gene Therapy Catapult Business Overview
12.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Introduction
12.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.13.5 Cell and Gene Therapy Catapult Recent Development
12.14 Biovian
12.14.1 Biovian Company Details
12.14.2 Biovian Business Overview
12.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Introduction
12.14.4 Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.14.5 Biovian Recent Development
12.15 Thermo Fisher Scientific (Brammer Bio)
12.15.1 Thermo Fisher Scientific (Brammer Bio) Company Details
12.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
12.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Introduction
12.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
12.16 VGXI
12.16.1 VGXI Company Details
12.16.2 VGXI Business Overview
12.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Introduction
12.16.4 VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.16.5 VGXI Recent Development
12.17 PlasmidFactory
12.17.1 PlasmidFactory Company Details
12.17.2 PlasmidFactory Business Overview
12.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Introduction
12.17.4 PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023)
12.17.5 PlasmidFactory Recent Development
13 Market Dynamics
13.1 Viral Vectors and Plasmid DNA Manufacturing Industry Trends
13.2 Viral Vectors and Plasmid DNA Manufacturing Market Drivers
13.3 Viral Vectors and Plasmid DNA Manufacturing Market Challenges
13.4 Viral Vectors and Plasmid DNA Manufacturing Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author List
15.3 Disclaimer
List of Tables
Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million): (2018 VS 2022 VS 2029)
Table 2. Major Players of Plasmid DNA
Table 3. Major Players of Viral Vectors
Table 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth by Application (2018 VS 2022 VS 2029)
Table 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
Table 6. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) Market Share by Region (2018-2023))
Table 7. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Region (2018-2023)
Table 8. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) Forecast by Region (2024-2029)
Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share Forecast by Region (2024-2029)
Table 10. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2018-2023) & (US$ Million)
Table 11. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Players (2018-2023)
Table 12. Global Viral Vectors and Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2022)
Table 13. Ranking of Global Top Viral Vectors and Plasmid DNA Manufacturing Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue (CR5 and HHI) & (2018-2023)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Viral Vectors and Plasmid DNA Manufacturing Product Solution and Service
Table 17. Date of Enter into Viral Vectors and Plasmid DNA Manufacturing Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 20. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2018-2023)
Table 21. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 22. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2024-2029)
Table 23. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 24. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2018-2023)
Table 25. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 26. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2024-2029)
Table 27. United States Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2018-2023) & (US$ Million)
Table 28. United States Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Company (2018-2023)
Table 29. United States Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023) & (K Units)
Table 30. United States Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029) & (K Units)
Table 31. United States Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023) & (K Units)
Table 32. United States Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029) & (K Units)
Table 33. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2018-2023) & (US$ Million)
Table 34. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Company (2018-2023)
Table 35. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 36. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029) & (US$ Million)
Table 37. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 38. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029) & (US$ Million)
Table 39. China Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2018-2023) & (US$ Million)
Table 40. China Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Company (2018-2023)
Table 41. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 42. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029) & (US$ Million)
Table 43. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 44. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029) & (US$ Million)
Table 45. Japan Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2018-2023) & (US$ Million)
Table 46. Japan Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Company (2018-2023)
Table 47. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 48. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029) & (US$ Million)
Table 49. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 50. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029) & (US$ Million)
Table 51. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2018-2023) & (US$ Million)
Table 52. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Company (2018-2023)
Table 53. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 54. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029) & (US$ Million)
Table 55. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 56. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029) & (US$ Million)
Table 57. India Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2018-2023) & (US$ Million)
Table 58. India Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Company (2018-2023)
Table 59. India Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2018-2023) & (US$ Million)
Table 60. India Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2024-2029) & (US$ Million)
Table 61. India Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2018-2023) & (US$ Million)
Table 62. India Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2024-2029) & (US$ Million)
Table 63. BioReliance Company Details
Table 64. BioReliance Description and Business Overview
Table 65. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product
Table 66. BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 67. BioReliance Recent Development
Table 68. Cobra Biologics Company Details
Table 69. Cobra Biologics Description and Business Overview
Table 70. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product
Table 71. Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 72. Cobra Biologics Recent Development
Table 73. Oxford BioMedica Company Details
Table 74. Oxford BioMedica Description and Business Overview
Table 75. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product
Table 76. Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 77. Oxford BioMedica Recent Development
Table 78. UniQure Company Details
Table 79. UniQure Description and Business Overview
Table 80. UniQure Viral Vectors and Plasmid DNA Manufacturing Product
Table 81. UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 82. UniQure Recent Development
Table 83. FinVector Company Details
Table 84. FinVector Description and Business Overview
Table 85. FinVector Viral Vectors and Plasmid DNA Manufacturing Product
Table 86. FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 87. FinVector Recent Development
Table 88. MolMed Company Details
Table 89. MolMed Description and Business Overview
Table 90. MolMed Viral Vectors and Plasmid DNA Manufacturing Product
Table 91. MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 92. MolMed Recent Development
Table 93. MassBiologics Company Details
Table 94. MassBiologics Description and Business Overview
Table 95. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product
Table 96. MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 97. MassBiologics Recent Development
Table 98. Richter-Helm Company Details
Table 99. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product
Table 100. Richter-Helm Description and Business Overview
Table 101. Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 102. Richter-Helm Recent Development
Table 103. FUJIFILM Diosynth Biotechnologies Company Details
Table 104. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product
Table 105. FUJIFILM Diosynth Biotechnologies Description and Business Overview
Table 106. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 107. FUJIFILM Diosynth Biotechnologies Recent Development
Table 108. Lonza Company Details
Table 109. Lonza Description and Business Overview
Table 110. Lonza Viral Vectors and Plasmid DNA Manufacturing Product
Table 111. Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 112. Lonza Recent Development
Table 113. Aldevron Company Details
Table 114. Aldevron Description and Business Overview
Table 115. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product
Table 116. Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 117. Aldevron Recent Development
Table 118. Eurogentec Company Details
Table 119. Eurogentec Description and Business Overview
Table 120. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product
Table 121. Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 122. Eurogentec Recent Development
Table 123. Cell and Gene Therapy Catapult Company Details
Table 124. Cell and Gene Therapy Catapult Description and Business Overview
Table 125. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product
Table 126. Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 127. Cell and Gene Therapy Catapult Recent Development
Table 128. Biovian Company Details
Table 129. Biovian Description and Business Overview
Table 130. Biovian Viral Vectors and Plasmid DNA Manufacturing Product
Table 131. Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 132. Biovian Recent Development
Table 133. Thermo Fisher Scientific (Brammer Bio) Company Details
Table 134. Thermo Fisher Scientific (Brammer Bio) Description and Business Overview
Table 135. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product
Table 136. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 137. Thermo Fisher Scientific (Brammer Bio) Recent Development
Table 138. VGXI Company Details
Table 139. VGXI Description and Business Overview
Table 140. VGXI Viral Vectors and Plasmid DNA Manufacturing Product
Table 141. VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 142. VGXI Recent Development
Table 143. PlasmidFactory Company Details
Table 144. PlasmidFactory Description and Business Overview
Table 145. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product
Table 146. PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2018-2023) & (US$ Million)
Table 147. PlasmidFactory Recent Development
Table 148. Viral Vectors and Plasmid DNA Manufacturing Market Trends
Table 149. Viral Vectors and Plasmid DNA Manufacturing Market Drivers
Table 150. Viral Vectors and Plasmid DNA Manufacturing Market Challenges
Table 151. Viral Vectors and Plasmid DNA Manufacturing Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type: 2022 VS 2029
Figure 2. Plasmid DNA Features
Figure 3. Viral Vectors Features
Figure 4. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2022 VS 2029
Figure 5. Cancers Case Studies
Figure 6. Inherited Disorders Case Studies
Figure 7. Viral Infections Case Studies
Figure 8. Others Case Studies
Figure 9. Viral Vectors and Plasmid DNA Manufacturing Report Years Considered
Figure 10. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Viral Vectors and Plasmid DNA Manufacturing Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Region: 2018 VS 2022
Figure 13. United States Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Growth Rate (2018-2029)
Figure 14. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Growth Rate (2018-2029)
Figure 15. China Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Growth Rate (2018-2029)
Figure 16. Japan Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Growth Rate (2018-2029)
Figure 17. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Growth Rate (2018-2029)
Figure 18. India Viral Vectors and Plasmid DNA Manufacturing Revenue (Million USD) Growth Rate (2018-2029)
Figure 19. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players in 2022
Figure 20. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2022
Figure 22. United States Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
Figure 23. United States Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
Figure 24. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
Figure 25. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
Figure 26. China Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
Figure 27. China Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
Figure 28. Japan Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2018-2029)
Figure 29. Japan Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2018-2029)
Figure 30. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Marke

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs